Metformin Dosing at Creatinine Clearance 34.4 mL/min
For a patient with a creatinine clearance of 34.4 mL/min (eGFR 30-44 mL/min/1.73 m²), reduce the metformin dose to half of the usual dose, with a maximum daily dose of 1000 mg. 1
Dosing Algorithm Based on Kidney Function
For eGFR 30-44 mL/min/1.73 m² (Your Patient's Range):
- If already on metformin: Halve the current dose 1
- Maximum daily dose: 1000 mg 2
- If initiating metformin: Start with 500 mg once daily 1
- Monitoring frequency: Check eGFR every 3-6 months 1
Practical Dosing Examples:
- If patient was on 2000 mg daily → reduce to 1000 mg daily 1
- If patient was on 1500 mg daily → reduce to 750 mg daily 1
- If patient was on 1000 mg daily → reduce to 500 mg daily 1
Key Safety Considerations
Metformin remains safe and appropriate at this level of kidney function when properly dose-adjusted. 1 The KDIGO 2022 guidelines explicitly recommend metformin use for patients with eGFR ≥30 mL/min/1.73 m² 1, and the FDA revised guidance in 2016 supports this approach 3, 4.
Critical Thresholds:
- eGFR ≥30 mL/min/1.73 m²: Metformin is safe with dose adjustment 3, 1, 4
- eGFR <30 mL/min/1.73 m²: Metformin is contraindicated and must be discontinued 3, 1, 4
- eGFR 30-44 mL/min/1.73 m²: Do not initiate metformin if patient is metformin-naïve, but continue with dose reduction if already established 1
Evidence Supporting Safety at This Level
Research demonstrates that metformin at appropriate doses in patients with eGFR 30-44 mL/min/1.73 m² shows no increased risk of lactic acidosis when dosed correctly 5, 6. A systematic review found no increase in acidosis risk except at eGFR <30 mL/min/1.73 m² 6. Post-hoc analysis from cardiovascular outcomes trials (EXSCEL and SAVOR-TIMI 53) confirmed neutral cardiovascular safety in CKD stages 3-4 7.
Monitoring Requirements
Increase monitoring frequency at this level of kidney function: 1
- Check eGFR every 3-6 months (more frequently than the annual monitoring for eGFR ≥60) 1
- Monitor vitamin B12 levels if metformin use exceeds 4 years 1
- Reassess benefit-risk if eGFR continues to decline toward 30 mL/min/1.73 m² 3
Contrast Media Precautions
For patients undergoing iodinated contrast imaging procedures: 3, 4, 2
- Discontinue metformin at the time of or prior to the procedure 3, 4
- Hold for 48 hours post-procedure 3, 4, 2
- Re-evaluate eGFR 48 hours after imaging before restarting 3, 4
- This applies to all patients with eGFR 30-60 mL/min/1.73 m² 3, 4
Common Pitfalls to Avoid
Do not continue full-dose metformin at this level of kidney function. The most common error is failing to dose-adjust when eGFR falls below 45 mL/min/1.73 m² 1. While metformin remains beneficial and safe at eGFR 30-44, the dose must be halved to prevent drug accumulation 1.
Do not automatically discontinue metformin at this eGFR level. Older guidelines were overly restrictive; current evidence supports continued use with appropriate dose reduction 3, 1, 6.